{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:39:35Z","timestamp":1792784375041,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medical Products Agency","id":[{"id":"https:\/\/ror.org\/0356c4a29","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1007\/s13181-018-0668-2","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T13:08:49Z","timestamp":1529413729000},"page":"265-271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Acute Intoxications Involving \u03b1-Pyrrolidinobutiophenone (\u03b1-PBP): Results from the Swedish STRIDA Project"],"prefix":"10.1007","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0648-3838","authenticated-orcid":false,"given":"Lisa","family":"Franz\u00e9n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda","family":"B\u00e4ckberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Helander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"668_CR1","unstructured":"EMCDDA. EU drug markets report 2016\u2014in-depth analysis. 2016. Available at: \n                    http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/2373\/TD0216072ENN.PDF\n                    \n                  ."},{"key":"668_CR2","unstructured":"EMCDDA. European Drug Report 2017: trends and developments. 2017. Available at: \n                    http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/4541\/TDAT17001ENN.pdf\n                    \n                  ."},{"key":"668_CR3","unstructured":"UNODC. World Drug Report 2017\u2014market analysis of synthetic drugs. 2017. Available at: \n                    https:\/\/www.unodc.org\/wdr2017\/field\/Booklet_4_ATSNPS.pdf\n                    \n                  ."},{"issue":"Pt 1","key":"668_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brainresbull.2016.04.011","volume":"126","author":"RA Glennon","year":"2016","unstructured":"Glennon RA, Young R. Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and alpha-pyrrolidinovalerophenone (alpha-PVP). Brain Res Bull. 2016;126(Pt 1):111\u201326. \n                    https:\/\/doi.org\/10.1016\/j.brainresbull.2016.04.011\n                    \n                  .","journal-title":"Brain Res Bull"},{"key":"668_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.forsciint.2009.05.001","volume":"190","author":"F Westphal","year":"2009","unstructured":"Westphal F, Junge T, R\u00f6sner P, S\u00f6nnichsen F, Schuster F. Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with \u03b1-pyrrolidinophenone structure. Forensic Sci Int. 2009;190:1\u20138. \n                    https:\/\/doi.org\/10.1016\/j.forsciint.2009.05.001\n                    \n                  .","journal-title":"Forensic Sci Int"},{"issue":"9","key":"668_CR6","doi-asserted-by":"publisher","first-page":"865","DOI":"10.3109\/15563650.2015.1089576","volume":"53","author":"O Beck","year":"2015","unstructured":"Beck O, Franz\u00e9n L, B\u00e4ckberg M, Signell P, Helander A. Intoxications involving MDPV in Sweden during 2010-2014: results from the STRIDA project. Clin Toxicol (Phila). 2015;53(9):865\u201373. \n                    https:\/\/doi.org\/10.3109\/15563650.2015.1089576\n                    \n                  .","journal-title":"Clin Toxicol (Phila)"},{"key":"668_CR7","unstructured":"EMCDDA. MDPV\u2014report on the risk assessment of 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one (3,4-methylenedioxypyrovalerone, MDPV) in the framework of the Council Decision on new psychoactive substances. 2014. Available at: \n                    http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/773\/TDAK14003ENN_480908.pdf\n                    \n                  ."},{"issue":"2","key":"668_CR8","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13181-014-0446-8","volume":"11","author":"BA Froberg","year":"2015","unstructured":"Froberg BA, Levine M, Beuhler MC, Judge BS, Moore PW, Engebretsen KM, et al. Acute methylenedioxypyrovalerone toxicity. J Med Toxicol. 2015;11(2):185\u201394. \n                    https:\/\/doi.org\/10.1007\/s13181-014-0446-8\n                    \n                  .","journal-title":"J Med Toxicol"},{"key":"668_CR9","unstructured":"Lindeman E, Feychting K. MDPV: new drug of abuse that has come to stay? L\u00e4kartidningen. 2015. Available at: \n                    http:\/\/lakartidningen.se\/Opinion\/Debatt\/2015\/05\/MDPV-ny-missbruksdrog-som-kommit-for-att-stanna\/\n                    \n                   Accessed March 2018."},{"key":"668_CR10","unstructured":"EMCDDA. Europol Joint Report on a new psychoactive substance: 1-phenyl-2-(1-pyrrolidinyl)-1-pentanone (\u03b1-PVP). 2015. Available at: \n                    http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/1814\/TDAS15001ENN.pdf\n                    \n                  ."},{"issue":"7","key":"668_CR11","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1080\/15563650.2016.1190979","volume":"54","author":"O Beck","year":"2016","unstructured":"Beck O, Franz\u00e9n L, B\u00e4ckberg M, Signell P, Helander A. Toxicity evaluation of alpha-pyrrolidinovalerophenone (alpha-PVP): results from intoxication cases within the STRIDA project. Clin Toxicol (Phila). 2016;54(7):568\u201375. \n                    https:\/\/doi.org\/10.1080\/15563650.2016.1190979\n                    \n                  .","journal-title":"Clin Toxicol (Phila)"},{"key":"668_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15563650.2017.1370097","volume":"56","author":"O Beck","year":"2017","unstructured":"Beck O, B\u00e4ckberg M, Signell P, Helander A. Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats. Clin Toxicol (Phila). 2017;56:1\u20138. \n                    https:\/\/doi.org\/10.1080\/15563650.2017.1370097\n                    \n                  .","journal-title":"Clin Toxicol (Phila)"},{"key":"668_CR13","unstructured":"Seeger E. \u03b1-Pyrrolidinyl ketones. US Patent 3312970. 1967. Available at: \n                    https:\/\/patentimages.storage.googleapis.com\/2a\/51\/4a\/1d08383ec607ff\/US3314970.pdf\n                    \n                   Accessed March 2018."},{"key":"668_CR14","unstructured":"EDND - European information system and datebase on new drugs. Available at: \n                    https:\/\/ednd.emcdda.europa.eu\n                    \n                  . Accessed March 2018."},{"key":"668_CR15","unstructured":"Flashback. Available at: \n                    https:\/\/www.flashback.org\n                    \n                  . Accessed March 2017."},{"key":"668_CR16","unstructured":"Bluelight. Available at: \n                    http:\/\/bluelight.org\n                    \n                  . Accessed March 2017."},{"issue":"5","key":"668_CR17","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3109\/00365513.2013.793817","volume":"73","author":"A Helander","year":"2013","unstructured":"Helander A, Beck O, H\u00e4gerkvist R, Hult\u00e9n P. Identification of novel psychoactive drug use in Sweden based on laboratory analysis\u2014initial experiences from the STRIDA project. Scand J Clin Lab Invest. 2013;73(5):400\u20136. \n                    https:\/\/doi.org\/10.3109\/00365513.2013.793817\n                    \n                  .","journal-title":"Scand J Clin Lab Invest"},{"key":"668_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.forsciint.2014.02.022","volume":"243","author":"A Helander","year":"2014","unstructured":"Helander A, B\u00e4ckberg M, Hult\u00e9n P, Al-Saffar Y, Beck O. Detection of new psychoactive substance use among emergency room patients: results from the Swedish STRIDA project. Forensic Sci Int. 2014;243:23\u20139. \n                    https:\/\/doi.org\/10.1016\/j.forsciint.2014.02.022\n                    \n                  .","journal-title":"Forensic Sci Int"},{"issue":"3","key":"668_CR19","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3109\/15563659809028940","volume":"36","author":"HE Persson","year":"1998","unstructured":"Persson HE, Sj\u00f6berg GK, Haines JA, Pronczuk de Garbino J. Poisoning severity score. Grading of acute poisoning. J Toxicol Clin Toxicol. 1998;36(3):205\u201313.","journal-title":"J Toxicol Clin Toxicol"},{"key":"668_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.jchromb.2013.04.043","volume":"930","author":"Y Al-Saffar","year":"2013","unstructured":"Al-Saffar Y, Stephanson NN, Beck O. Multicomponent LC-MS\/MS screening method for detection of new psychoactive drugs, legal highs, in urine-experience from the Swedish population. J Chromatogr B Analyt Technol Biomed Life Sci. 2013;930:112\u201320. \n                    https:\/\/doi.org\/10.1016\/j.jchromb.2013.04.043\n                    \n                  .","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"8","key":"668_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/jms.3946","volume":"52","author":"NN Stephanson","year":"2017","unstructured":"Stephanson NN, Signell P, Helander A, Beck O. Use of LC-HRMS in full scan-XIC mode for multi-analyte urine drug testing\u2014a step towards a \u2018black-box\u2019 solution? J Mass Spectrom. 2017;52(8):497\u2013506. \n                    https:\/\/doi.org\/10.1002\/jms.3946\n                    \n                  .","journal-title":"J Mass Spectrom"},{"issue":"5","key":"668_CR22","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3171\/jns.1988.69.5.0699","volume":"69","author":"JE Starmark","year":"1988","unstructured":"Starmark JE, St\u00e5lhammar D, Holmgren E, Rosander B. A comparison of the Glasgow Coma Scale and the Reaction Level Scale (RLS85). J Neurosurg. 1988;69(5):699\u2013706. \n                    https:\/\/doi.org\/10.3171\/jns.1988.69.5.0699\n                    \n                  .","journal-title":"J Neurosurg"},{"issue":"1","key":"668_CR23","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3109\/15563650.2014.981823","volume":"53","author":"M B\u00e4ckberg","year":"2015","unstructured":"B\u00e4ckberg M, Lindeman E, Beck O, Helander A. Characteristics of analytically confirmed 3-MMC-related intoxications from the Swedish STRIDA project. Clin Toxicol (Phila). 2015;53(1):46\u201353. \n                    https:\/\/doi.org\/10.3109\/15563650.2014.981823\n                    \n                  .","journal-title":"Clin Toxicol (Phila)."},{"issue":"4","key":"668_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3109\/15563650.2016.1139715","volume":"54","author":"A Helander","year":"2016","unstructured":"Helander A, B\u00e4ckberg M, Beck O. Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project. Clin Toxicol (Phila). 2016;54(4):324\u201332. \n                    https:\/\/doi.org\/10.3109\/15563650.2016.1139715\n                    \n                  .","journal-title":"Clin Toxicol (Phila)."},{"issue":"2","key":"668_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1476-5381.2012.02145.x","volume":"168","author":"LD Simmler","year":"2013","unstructured":"Simmler LD, Buser TA, Donzelli M, Schramm Y, Dieu LH, Huwyler J, et al. Pharmacological characterization of designer cathinones in vitro. Br J Pharmacol. 2013;168(2):458\u201370. \n                    https:\/\/doi.org\/10.1111\/j.1476-5381.2012.02145.x\n                    \n                  .","journal-title":"Br J Pharmacol"},{"issue":"4","key":"668_CR26","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/npp.2012.204","volume":"38","author":"MH Baumann","year":"2013","unstructured":"Baumann MH, Partilla JS, Lehner KR, Thorndike EB, Hoffman AF, Holy M, et al. Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive \u2018bath salts\u2019 products. Neuropsychopharmacology. 2013;38(4):552\u201362. \n                    https:\/\/doi.org\/10.1038\/npp.2012.204\n                    \n                  .","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"668_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1124\/jpet.116.236349.","volume":"360","author":"AJ Eshleman","year":"2017","unstructured":"Eshleman AJ, Wolfrum KM, Reed JF, Kim SO, Swanson T, Johnson RA, et al. Structure-activity relationships of substituted cathinones, with transporter binding, uptake, and release. J Pharmacol Exp Ther. 2017;360(1):33\u201347. \n                    https:\/\/doi.org\/10.1124\/jpet.116.236349.","journal-title":"J Pharmacol Exp Ther"},{"key":"668_CR28","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.neuropharm.2014.02.016","volume":"87","author":"JA Marusich","year":"2014","unstructured":"Marusich JA, Antonazzo KR, Wiley JL, Blough BE, Partilla JS, Baumann MH. Pharmacology of novel synthetic stimulants structurally related to the \u201cbath salts\u201d constituent 3,4-methylenedioxypyrovalerone (MDPV). Neuropharmacology. 2014;87:206\u201313. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2014.02.016\n                    \n                  .","journal-title":"Neuropharmacology"},{"issue":"1","key":"668_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.lfs.2013.07.023","volume":"97","author":"CL German","year":"2014","unstructured":"German CL, Fleckenstein AE, Hanson GR. Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sci. 2014;97(1):2\u20138. \n                    https:\/\/doi.org\/10.1016\/j.lfs.2013.07.023\n                    \n                  .","journal-title":"Life Sci"},{"key":"668_CR30","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.scitotenv.2013.11.095","volume":"487","author":"A Kankaanpaa","year":"2014","unstructured":"Kankaanpaa A, Ariniemi K, Heinonen M, Kuoppasalmi K, Gunnar T. Use of illicit stimulant drugs in Finland: a wastewater study in ten major cities. Sci Total Environ. 2014;487:696\u2013702. \n                    https:\/\/doi.org\/10.1016\/j.scitotenv.2013.11.095\n                    \n                  .","journal-title":"Sci Total Environ"},{"issue":"2","key":"668_CR31","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s11419-013-0192-7","volume":"31","author":"A Namera","year":"2013","unstructured":"Namera A, Urabe S, Saito T, Torikoshi-Hatano A, Shiraishi H, Arima Y, et al. A fatal case of 3,4-methylenedioxypyrovalerone poisoning: coexistence of alpha-pyrrolidinobutiophenone and alpha-pyrrolidinovalerophenone in blood and\/or hair. Forensic Toxicol. 2013;31(2):338\u201343. \n                    https:\/\/doi.org\/10.1007\/s11419-013-0192-7\n                    \n                  .","journal-title":"Forensic Toxicol"},{"key":"668_CR32","unstructured":"EMCDDA. High-risk drug use and new psychoactive substances: Results from an EMCDDA tredspotter study. 2017. Available at: \n                    http:\/\/www.emcdda.europa.eu\/system\/files\/publications\/4540\/TD0217575ENN.pdf\n                    \n                  ."}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-018-0668-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-018-0668-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-018-0668-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T19:34:39Z","timestamp":1560886479000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-018-0668-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["668"],"URL":"https:\/\/doi.org\/10.1007\/s13181-018-0668-2","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"assertion":[{"value":"8 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The STRIDA project is conducted in accordance with the Helsinki Declaration, and it has been approved by the regional ethical review board (Nr. 2013\/116\u201331\/2).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Sources of Funding"}}]}}